Related Experiment Video
Updated: Aug 23, 2025

06:08
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
1.3K
BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5
Sara Y Tartof1, Jeff M Slezak2, Laura Puzniak3
1Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA; Department of Health Systems Science, Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, CA USA.
The Lancet. Infectious Diseases
|October 28, 2022
Abstract
No abstract available in PubMed .

